Z-band alternatively spliced PDZ motif protein (ZASP) is the major o-linked β-N-acetylglucosamine-substituted protein in human heart myofibrils

Journal of Biological Chemistry

Volumn 288, Issue 7, 2013, Pages 4891-4898

  Leung, Man Ching ^a   Hitchen, Paul G ^b   Ward, Douglas G ^c   Messer, Andrew E ^a   Marston, Steven B ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HEART; MECHANOTRANSDUCTION; MYOFIBRILS; O-LINKED; SARCOMERIC PROTEIN;

BIOCHEMISTRY; BIOLOGY;

PROTEINS;

ALPHA ACTININ; CONTRACTILE PROTEIN; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; O LINKED BETA N ACETYLGLUCOSAMINE; UDP N AZIDOACETYLGALACTOSAMINE; UNCLASSIFIED DRUG; Z BAND ALTERNATIVELY SPLICED PDZ MOTIF PROTEIN; Z BAND ALTERNATIVELY SPLICED PDZ MOTIF PROTEIN 1; Z BAND ALTERNATIVELY SPLICED PDZ MOTIF PROTEIN 2; Z BAND ALTERNATIVELY SPLICED PDZ MOTIF PROTEIN 3; Z BAND ALTERNATIVELY SPLICED PDZ MOTIF PROTEIN 5;

ANIMAL CELL; ARTICLE; CONJUGATION; CONTROLLED STUDY; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; MUSCLE FIBRIL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PROCESSING; SARCOMERE; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

ACETYLGLUCOSAMINE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; HEART; HUMANS; LIM DOMAIN PROTEINS; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; MYOFIBRILS; PEPTIDES; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84874096862     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.410316     Document Type: Article

References (40)

1. Torres, C. R., and Hart, G. W. (1984) Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes: evidence for O-linked GlcNAc. J. Biol. Chem. 259, 3308-3317
2. Hart, G. W., Slawson, C., Ramirez-Correa, G., and Lagerlof, O. (2011) Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Ann. Rev. Biochem. 80, 825-858
3. Lunde, I. G., and Aronsen., J. M., Kvaløy, H., Qvigstad, E., Sjaastad, I., Tønnessen, T., Christensen, G., Grønning-Wang, L. M., and Carlson, C. R. (2012) Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure. Physiol. Genomics 44, 162-172
4. Belke, D.D. (2011) Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart. J. Appl. Physiol. 111, 157-162
5. 2+ activation properties of rat skeletal muscle. J. Biol. Chem. 282, 10360-10369
6. Jones, S. P., and Zachara., N. E., Ngoh, G. A., Hill, B. G., Teshima, Y., Bhatnagar, A., Hart, G. W., and Marbán, E. (2008) Cardioprotection by N-acetylglu-cosamine linkage to cellular proteins. Circulation 117, 1172-1182
7. Ramirez-Correa, G. A., Jin, W., Wang, Z., Zhong, X., Gao, W. D., and Dias., W. B., Vecoli, C, Hart, G. W., and Murphy, A. M. (2008) O-Linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function. Circ. Res. 103, 1354-1358
8. Hédou, J., Bastide, B., Page, A., Michalski, J.-C, and Morelle, W. (2009) Mapping of O-linked β-N-acetylglucosamine modification sites in key contractile proteins of rat skeletal muscle. Proteomics 9, 2139-2148
9. Cieniewski-Bernard, C, Bastide, B., Lefebvre, T., Lemoine, J., Mounier, Y., and Michalski, J. C. (2004) Identification of O-linked N-acetylglucosamine proteins in rat skeletal muscle using two-dimensional gel electrophoresis and mass spectrometry. Mol. Cell. Proteomics 3, 577-585
10. Sheikh, F., and Bang., M. L., Lange, S., and Chen, J. (2007) "Z"eroing in on the role of Cypher in striated muscle function, signaling, and human disease. Trends Cardiovasc. Med. 17, 258-262
11. Jacques, A. M., Copeland, O., Messer, A. E., and Gallon., C. E., King, K., McKenna, W. J., and Tsang., V. T., and Marston, S. B. (2008) Myosin binding protein C phosphorylation in normal, hypertrophic, and failing human heart muscle. J. Mol. Cell Cardiol. 45, 209-216
12. Jacques, A. M., Briceno, N, and Messer., A. E., Gallon, C. E., Jalilzadeh, S., Garcia, E., Kikonda-Kanda, G., Goddard, J., Harding, S. E., Watkins, H, Esteban, M. T., Tsang, V. T., McKenna, W. J., and Marston, S. B. (2008) The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy. Cardiovasc. Res. 79, 481-491
13. Messer, A. E., and Gallon., C. E., McKenna, W. J., Dos Remedios, C. G., and Marston, S. B. (2009) The use of phosphate-affinity SDS-PAGE to measure the cardiac troponin I phosphorylation site distribution in human heart muscle. Proteomics Clin. Appl. 3, 1371-1382
14. Messer, A. E., and Jacques., A. M., and Marston, S. B. (2007) Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J. Mol. Cell Cardiol. 42, 247-259
15. Fülöp, N, Mason, M. M., Dutta, K., Wang, P., Davidoff, A. J., Marchase, R. B., and Chatham, J. C. (2007) Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. Am. J. Physiol. Cell Physiol. 292, C1370-C1378
16. Khidekel, N, Arndt, S., Lamarre-Vincent, N, Lippert, A., Poulin-Kerstien, K. G., Ramakrishnan, B., Qasba, P. K., and Hsieh-Wilson, L. C. (2003) A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications. J. Am. Chem. Soc. 125, 16162-16163
17. Khidekel, N, and Ficarro., S. B., Clark, P. M., Bryan, M. C, Swaney, D. L., Rexach, J. E., Sun, Y. E., Coon, J. J., Peters, E. C, and Hsieh-Wilson, L. C. (2007) Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. Nat Chem. Biol. 3, 339-348
18. 2+ sensitivity and cross-bridge cycling. J. Biol. Chem. 285, 5674-5682
19. 2+ desensitization. Circulation 124, (Abstr. A16695)
20. Watson, L. J., and Facundo., H. T., Ngoh, G. A., Ameen, M., Brainard, R. E., and Lemma., K. M., Long, B. W., Prabhu, S. D., Xuan, Y.-T., and Jones, S. P. (2010) O-Linked β-N-acetylglucosamine transferase is indispensable in the failing heart. Proc. Natl. Acad. Sci. U.S.A. 107, 17797-17802
21. Wang, Z., Pandey, A., and Hart, G. W. (2007) Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. Mol. Cell. Proteomics 6,1365-1379
22. Wang, Z., and Udeshi., N. D., O'Malley, M., Shabanowitz, J., Hunt, D. F., and Hart, G. W. (2010) Enrichment and site mapping of O-linked N-acetylglucosamine by a combination of chemical/enzymatic tagging, photochemical cleavage, and electron transfer dissociation mass spectrometry. Mol. Cell. Proteomics 9, 153-160
23. Isono, T. (2011) O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation. PloS one 6, e18959
24. Zheng, M., Cheng, H, Banerjee, I., and Chen, J. (2010) ALP/Enigma PDZ-LIM domain proteins in the heart. J. Mol. Cell. Biol. 2, 96-102
25. Huang, C., Zhou, Q., Liang, P., Hollander, M. S., Sheikh, F., Li, X., Greaser, M., Shelton, G. D., Evans, S., and Chen, J. (2003) Characterization and in vivo functional analysis of splice variants of Cypher. J. Biol. Chem. 278, 7360-7365
26. Au, Y., and Atkinson., R. A., Guerrini, R., Kelly, G., Joseph, C., and Martin., S. R., Muskett, F. W., Pallavicini, A., Faulkner, G., and Pastore, A. (2004) Solution structure of ZASP PDZ domain; implications for sarcomere ultrastructure and enigma family redundancy. Structure 12, 611-622
27. Faulkner, G., Pallavicini, A., Formentin, E., Comelli, A., Ievolella, C., Trevisan, S., Bortoletto, G., Scannapieco, P., Salamon, M., Mouly, V., Valle, G., and Lanfranchi, G. (1999) ZASP: a new Z-band alternatively spliced PDZ-motif protein. J. Cell Biol. 146, 465-475
28. von Nandelstadh, P., Ismail, M., Gardin, C., Suila, H., Zara, I., Belgrano, A., Valle, G., Carpen, O., and Faulkner, G. (2009) A class III PDZ binding motif in the myotilin and FATZ families binds enigma family proteins: a common link for Z-disc myopathies. Mol. Cell. Biol. 29, 822-834
29. Zhou, Q., and Chu., P. H., Huang, C., Cheng, C. F., and Martone., M. E., Knoll, G., Shelton, G. D., Evans, S., and Chen, J. (2001) Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J. Cell Biol. 155, 605-612
30. Xing, Y., Ichida, F., Matsuoka, T., Isobe, T., Ikemoto, Y., Higaki, T., Tsuji, T., Haneda, N., Kuwabara, A., Chen, R., Futatani, T., Tsubata, S., Watanabe, S., Watanabe, K., Hirono, K., Uese, K., Miyawaki, T., Bowles, K. R., Bowles, N. E., and Towbin, J. A. (2006) Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Mol. Genet. Metab. 88, 71-77
31. Arimura, T., Inagaki, N., Hayashi, T., Shichi, D., Sato, A., Hinohara, K., Vatta, M., and Towbin., J. A., Chikamori, T., Yamashina, A., and Kimura, A. (2009) Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy. Cardiovasc. Res. 83, 80-88
32. Theis, J. L., and Bos., J. M., Bartleson, V. B., Will, M. L., Binder, J., Vatta, M., Towbin, J. A., and Gersh., B. J., Ommen, S. R., and Ackerman, M. J. (2006) Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 351, 896-902
33. Vatta, M., Mohapatra, B., Jimenez, S., Sanchez, X., Faulkner, G., Perles, Z., Sinagra, G., Lin, J.-H., Vu, T. M., Zhou, Q., Bowles, K. R., Di Lenarda, A., Schimmenti, L., Fox, M., Chrisco, M. A., Murphy, R. T., McKenna, W., Elliott, P., Bowles, N. E., Chen, J., Valle, G., and Towbin, J. A. (2003) Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J. Am. Coll. Cardiol. 42, 2014-2027
34. Knöll, R., Hoshijima, M., and Chien, K. (2003) Cardiac mechanotransduction and implications for heart disease. J. Mol. Med. 81, 750-756
35. Buyandelger, B., Ng, K.-E., Miocic, S., Gunkel, S., Piotrowska, I., Ku, C.-H., and Knöll, R. (2011) Genetics of mechanosensation in the heart. J. Cardiovasc. Transl. Res. 4, 238-244
36. Brainard, R., and Jones, S. P. (2011) Reduced protein O-GlcNAcylation exacerbates pressure overload induced ventricular dysfunction. Circulation 124, (Abstr. A17366)
37. Ramirez-Correa, G., Slawson, C, Wei, D., Hart, G.W., and Murphy, A. M. (2011) Increased cardiac O-GlcNAc transferase and O-GlcNAcase association to actin, tropomyosin, and MLC 1 in diabetes: A mechanism for O-GlcNAc mediated myofilament calcium desensitization. Biophys. J. 100, 451a
38. Marston, S., Copeland, O., Jacques, A., Livesey, K., Tsang, V., McKenna, W. J., Jalilzadeh, S., Carballo, S., Redwood, C, and Watkins, H. (2009) Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ. Res. 105, 219-222
39. Copeland, O., Sadayappan, S., Messer, A. E., and Steinen., G. J., van der Velden, J., and Marston, S. B. (2010) Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle. J. Mol. Cell Cardiol. 49, 1003-1011
40. 2+ sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T. Cardiovasc. Res. 10.1093/ cvr/cvs322